Accessibility Menu
Evolent Health logo

Evolent Health(NYSE) EVH

Current Price$4.85
Market Cap$626.52MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2015)-70%
5 Year-75%
1 Year-43%
1 Month+24%
Evolent Health last closing stock price
MetricPriceDate
Last closeUSD 5.572026-07-22
Evolent Health stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-5.11%USD 5.872026-07-15
1 month+24.33%USD 4.482026-06-22
3 month+88.81%USD 2.952026-04-23
Year to date+39.25%USD 4.002025-12-31
1 year-42.99%USD 9.772025-07-22
3 year-82.15%USD 31.212023-07-21
5 year-74.5%USD 21.842021-07-23
Since inception-70.47%USD 18.862015-06-05

Evolent Health Financials at a Glance

Market Cap

$626.52MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$1.89B

Net Income (TTM)

-$496.52M

EPS (TTM)

-$4.76

P/E Ratio

-1.17

Dividend

$0.00

Beta (Volatility)

0.92 (Low)

Price

$4.85

Volume

69,717

Open

$5.35

Previous Close

$5.57

Daily Range

$4.72 - $5.39

52-Week Range

$2.10 - $10.35

Estimated Earnings Date

Aug 6, 2026

EVH News

Foolcom-Featured.png

EVH Earnings Drop 31%

Motley Fool Markets TeamAug 7, 2025
Big fish eating little fish

Why Evolent Health Stock Is Soaring Today

Keith SpeightsNov 18, 2022
Medical professional with hand on head

Why Evolent Health Stock Sank by Over 6% Today

Eric VolkmanNov 16, 2022
Patient and physician smiling during a visit

Why Evolent Health Was Such a Healthy Stock Today

Eric VolkmanAug 3, 2022
Medical professional working at a computer terminal

Why Evolent Health Stock Crept Higher Today

Eric VolkmanJun 29, 2022
evolent

Why Shares of Evolent Health Jumped 22% Thursday

James HalleyFeb 24, 2022
happy-investor-with-hands-behind-his-head-and-laptop

Here's Why Evolent Health Is Up 18.8% This Week

Cory RenauerOct 1, 2021
Stethoscope atop 100 dollar bills and pennies

Why Evolent Health Blasted 7% Higher on Thursday

Eric VolkmanSep 30, 2021
Page 1

EVH: Motley Fool Moneyball Superscore

46

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Evolent Health

Evolent Health helps doctors manage care for patients with complex illnesses like cancer. It connects health plans and medical providers to ensure treatments follow proven clinical guidelines. This system helps lower healthcare costs while improving how patients receive specialized care.

Connecting Doctors and Data

  • Specialty Care Management: Clinical programs for cancer, heart disease, and bone health that help doctors choose the best treatments.
  • Administrative Services: Operational tools for health plans including billing, claim processing, and data reporting.
  • Identifi Technology: Software platform that gathers medical data to help health professionals see a full view of patient care.
  • CarePro Platform: Specialized workflow tool used by doctors to manage specific treatment plans for oncology and cardiology.

Strategic Deals and Divestitures

  • Purchased New Century Health in 2018 to gain expertise in managing specialty care for Medicare members.
  • Acquired Machinify to add artificial intelligence tools that help medical staff review treatment requests faster.
  • Consummated the sale of Evolent Care Partners in December 2025 to focus on core specialty care operations.
  • Integrated NIA and IPG to expand services into medical imaging and surgical management for musculoskeletal conditions.

How the Company Operates

The company uses a proprietary technology system to reduce clinical variation and remove barriers to specialized care. By aligning financial incentives with evidence-based medicine, Evolent seeks to lower medical expenses for health plans.

The Latest Financial Performance

  • Revenue was $468.7 million in Q4 2025, down 27.5% from $646.5 million in Q4 2024.
  • Net income was a loss of $429.1 million in Q4 2025, which deepened from a loss of $22.8 million the year before.
  • Free cash flow reached $41 million in Q4 2025, turning positive from a loss of $32.4 million in Q4 2024.
  • Operating income was a loss of $9.6 million in Q4 2025, which narrowed from a loss of $18.6 million in Q4 2024.

Evolution into Specialty Care

Evolent has shifted from providing general administrative support to managing high-cost clinical conditions through technology and risk-sharing contracts. Its focus on oncology and cardiology allows it to participate in the medical savings created by improved patient care.

AI Generated • May 6, 2026

Industry

Health Care Technology

Sector

Health Care

Employees

4,200

CEO

Seth B. Blackley, MBA

Website

www.evolent.com

Headquarters

Arlington, VA 22203, US

EVH Financials

Key Financial Metrics (TTM)

Gross Margin

14.13%

Operating Margin

-0.86%

Net Income Margin

-26.29%

Return on Equity

-77.89%

Return on Capital

-0.32%

Return on Assets

-26.43%

Earnings Yield

-85.47%

Dividend Yield

0.00%

Payout Ratio

-1.32%

Stock Overview

Market Cap

$626.52MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

112.48M

Volume

69.72K

Avg. Volume

2.51M

Financials (TTM)

Gross Profit

$266.94M

Operating Income

-$16.29M

EBITDA

-$314.51M

Operating Cash Flow

$33.29M

Capital Expenditure

-$31.90M

Free Cash Flow

$1.40M

Cash & ST Invst.

$166.01M

Total Debt

$985.43M

Evolent Health Performance Analysis

Evolent Health annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 1,352,013,00048.9%
20232023-12-31USD 1,963,896,00045.3%
20242024-12-31USD 2,554,741,00030.1%
20252025-12-31USD 1,876,229,000-26.6%
Evolent Health sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-8.1%
Q32025-09-307.9%
Q42025-12-31-2.3%
Q12026-03-315.9%
Evolent Health annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.20-44.3%
20232023-12-31USD -1.28541.9%
20242024-12-31USD -0.81-36.3%
20252025-12-31USD -5.07522.6%
Evolent Health sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3030.2%
Q32025-09-3045.5%
Q42025-12-31-1466.7%
Q12026-03-3193.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$496.25M

+2.6%

Gross Profit

$61.92M

-39.6%

Gross Margin

12.48%

N/A

Market Cap

$626.52MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$149.17K

N/A

Employees

4,200

N/A

Net Income

-$26.63M

+58.8%

EBITDA

$13.63M

+147.5%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$166.01M

-32.7%

Total Debt

$985.43M

+13.3%

Accounts Receivable

$314.16M

-27.0%

Inventory

$0.00

N/A

Long Term Debt

$976.65M

+47.3%

Short Term Debt

$8.78M

-95.8%

Return on Assets

-26.43%

N/A

Return on Invested Capital

-1.09%

N/A

Free Cash Flow

-$7.39M

-83.4%

Operating Cash Flow

-$984.00K

-121.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MYGNMyriad Genetics, Inc.
$5.70+0.79%
HSTMHealthStream, Inc.
$26.60-1.09%
REPLReplimune Group, Inc.
$10.75-0.05%
NUTXNutex Health, Inc.
$153.67-2.25%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.78-0.29%
NOKNokia
$9.82-0.05%
AALAmerican Airlines Group
$13.56-0.08%
TQQQProShares Trust - ProShares UltraPro Qqq
$65.22-0.07%

Questions About EVH

What is the current price of Evolent Health?

Evolent Health is trading at $4.85 per share.

What is the 52-week range for Evolent Health?

Over the past 52 weeks, Evolent Health has traded between $2.10 and $10.35.

How much debt does Evolent Health have?

As of the most recent reporting period, Evolent Health reported total debt of $985.43M.

How much cash does Evolent Health have on hand?

Evolent Health reported $166.01M in cash and cash equivalents in its most recent financial results.

What is Evolent Health’s dividend yield?

Evolent Health does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services